A CT cardiac calcium score measures the amount of calcified plaque in your coronary arteries, giving you and your doctor a direct look at whether atherosclerosis is already developing. Unlike cholesterol tests or blood pressure readings, which estimate your risk based on indirect markers, this scan shows actual buildup in the arteries that supply blood to your heart. That distinction is why the test exists: it moves the conversation from “you might develop heart disease” to “here’s what’s already happening in your arteries.”
What the Scan Actually Measures
The CT scanner takes images of your heart timed to your heartbeat, capturing thin cross-sections of your coronary arteries. The scan is looking for calcium deposits, which form inside arterial plaque as it hardens over time. Any spot brighter than a specific density threshold on the image gets flagged as a calcified lesion. The software then multiplies the area of each lesion by a weight based on how dense the calcium is. All those individual scores get added up into a single number called the Agatston score, named after the cardiologist who developed the method.
The whole process takes about 10 minutes, requires no contrast dye, and delivers a radiation dose of roughly 1 to 2 millisieverts, comparable to a mammogram. You lie still, hold your breath for a few seconds while the scanner captures images, and you’re done.
Why the Score Matters for Predicting Heart Disease
The core value of calcium scoring is its ability to stratify risk far more precisely than traditional calculators that rely on age, cholesterol, blood pressure, and smoking status. Those calculators are useful population-level tools, but they can’t tell you whether plaque has actually formed in your specific arteries. A calcium score can.
The numbers are striking. In a study of over 1,000 people with type 2 diabetes followed for about seven years, those with a score of 100 or higher had a mortality rate of 20%, compared to 6.7% for those with a score of zero. Other large studies have found that a score above 100 carries roughly three to four times the cardiovascular risk of a zero score, and scores above 400 push that risk even higher. One long-term analysis found 10-year survival was 99% for people with a score of zero but dropped to 74 to 78% for scores above 1,000.
The risk gradient is consistent across different populations and study designs. People with higher scores have more plaque, and more plaque means more danger. That simplicity is part of why the test is so useful.
What Different Score Ranges Mean
A score of zero means no detectable calcified plaque was found. This is the best possible result, and it carries genuinely reassuring short-term implications. Event rates in this group are very low, and both the American College of Cardiology and the American Heart Association recognize a zero score as a reason to potentially defer statin therapy in people whose risk is borderline.
That said, a zero score is not a guarantee of safety. Research from the Multi-Ethnic Study of Atherosclerosis found that roughly one-quarter to one-third of cardiovascular events still occur in people with a score of zero. Part of this is because the scan only detects calcified, or “hard,” plaque. It cannot see soft plaque, which is the newer, less stable type that can rupture and trigger a heart attack. So a clean calcium score lowers your statistical risk substantially but doesn’t eliminate it.
Scores between 1 and 99 indicate mild plaque buildup. Scores of 100 to 399 represent moderate buildup and a meaningfully elevated risk. Scores of 400 or above signal extensive calcification and warrant aggressive prevention strategies. These categories aren’t arbitrary cutoffs; they correspond to progressively higher rates of heart attack, stroke, and death across dozens of studies.
Who Should Get the Test
The 2018 ACC/AHA guidelines and the 2021 European Society of Cardiology guidelines recommend calcium scoring for risk refinement in people without symptoms who fall into an intermediate risk category, typically defined as a 5 to 20% estimated 10-year risk of cardiovascular disease. This is the group where the test adds the most clarity. If your risk is already clearly high, you likely need treatment regardless. If your risk is very low, the scan is unlikely to change the plan.
The test is also particularly useful for people with a family history of premature heart disease whose calculated risk comes in below 5%. Standard risk calculators can underestimate danger in this group because family history doesn’t always get enough weight in the formula. Cleveland Clinic cardiologists have noted they also use the scan for intermediate-risk patients who are reluctant to start medication and want a more personalized picture of what’s happening in their arteries. Seeing a number, especially a high one, can change the conversation.
Calcium scoring is less helpful in younger adults. Plaque calcification takes time to develop, and the median age when it becomes detectable is in the 40s and 50s. A young person with significant soft plaque but no calcification yet could get a falsely reassuring zero score.
How Results Change Treatment Decisions
One of the most practical reasons to get a calcium score is its direct impact on whether you start preventive medication. In the CLARIFY study, which examined how calcium scoring affected statin decisions, about 25 to 30% of patients had their statin eligibility reclassified after seeing their results. Some people who didn’t qualify for a statin based on traditional risk scores were bumped up after a high calcium score. Others who were borderline candidates were downgraded after a reassuring zero.
This reclassification matters because statins carry side effects and costs, and many people are understandably hesitant to take a daily medication for decades based on a percentage from a calculator. A calcium score gives both patient and doctor something concrete to point to. If your arteries are already accumulating plaque, the case for treatment becomes much more compelling. If they’re clean, you may reasonably decide to focus on lifestyle changes and recheck in a few years.
Cost and Insurance Coverage
Despite strong guideline support, nearly all insurance payers, including Medicare, continue to deny coverage for calcium scoring when it’s used for primary prevention risk assessment. This is a point of ongoing frustration in the cardiology community. The American Heart Association has publicly argued that insurers should cover the test.
The silver lining is that many hospitals and imaging centers have dropped their cash price to the $50 to $100 range, making it one of the more affordable cardiac tests you can get out of pocket. Given that the results can guide years of treatment decisions, that price point represents strong value for people in the intermediate-risk group where the test is most informative.
What the Scan Cannot Tell You
Calcium scoring has a specific blind spot: it only detects hard, calcified plaque. Soft plaque, the type that is newer, potentially more unstable, and sometimes more likely to rupture, does not show up on this scan. A coronary CT angiography, which uses contrast dye, can visualize both hard and soft plaque and gives a more complete picture of the total plaque burden. But angiography involves more radiation, more cost, and more complexity, so it’s not used as a first-line screening tool.
This limitation is why a zero calcium score, while reassuring, should not be treated as proof that your arteries are perfectly healthy. It means no calcified plaque was detected. That’s a strong signal, but it’s not the whole story, particularly for younger patients or those with risk factors like high inflammatory markers that contribute to soft plaque formation.